In November, MesotheliomaHelp reported the U.S. Food and Drug Administration granted accelerated approval for the anti-cancer drug Tagrisso (osimertinib) for lung cancer. This approval opened the door for another mesothelioma treatment as well. Now, researchers report exciting results from a ...
Enter email for updates from this topic
Want Specific topic updates?